Worth reading
47Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
179700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights for compensation purposes (stock compensation stock options)
Who receives how much
179,700 shares of the Company's common stock (599 stock acquisition rights, 300 shares per right)
The Company's executive officers15 / 163,500 shares
Directors and others of the Company's group companies4 / 16,200 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Fair value for accounting purposes as of the allotment date
Amount of funds to be raised
Payment for the stock acquisition rights: ¥0; estimated net proceeds: ¥0
Terms of the stock acquisition rights
Exercise price
¥1 per share. No adjustment provisions.
Exercise period
Start Date 21 July 2026 / End date 20 July 2041
Number of Stock Acquisition Rights
Total number issued: 599; number remaining unexercised: Not disclosed
Reason for acquisition without consideration
After the exercise period has expired or 5 years have elapsed from the date of retirement, A serious violation of laws, regulations or internal rules, If the holder is sentenced to imprisonment or a more severe penalty, If the holder assumes or agrees to assume a position as an officer or employee of a competing company without the Company's prior approval, If a successor to the rights dies, If the holder of the stock acquisition rights offers to waive all of them, If the Board of Directors resolves to acquire all or part of the stock acquisition rights
Categories and Number of Persons Covered
Category The Company's executive officers / Number of Employees 15 / Number of allocated shares 163,500 shares, Category Directors and others of the Company's group companies / Number of Employees 4 / Number of allocated shares 16,200 shares
Intended allottee's holding policy
The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral.
Payment date
Not applicable (no cash payment required)
Basis for determining the amount to be paid
The issue price of the stock acquisition rights will be their accounting fair value as of the allotment date. The exercise price is ¥1 per share. The closing price, average share price, and discount or premium rate are Not disclosed.
Procedures under the Corporate Code of Conduct
Approved by the Compensation Committee and the Board of Directors on 28 May 2025. The specific issuance terms were determined by the Compensation Committee and the Board of Directors on 9 April 2026.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights for compensation purposes (stock compensation stock options) |
| Number of shares to be issued or disposed of | 179,700 shares of the Company's common stock (599 stock acquisition rights, 300 shares per right) |
| Issue price and disposal price | Fair value for accounting purposes as of the allotment date |
| Amount of funds to be raised | Payment for the stock acquisition rights: ¥0; estimated net proceeds: ¥0 |
| Payment date | Not applicable (no cash payment required) |
| Intended allottee | Category The Company's executive officers / Number of Employees 15 / Number of stock acquisition rights 545 / Number of underlying shares 163,500 shares, Category Directors and others of the Company's group companies / Number of Employees 4 / Number of stock acquisition rights 54 / Number of underlying shares 16,200 shares |
| Intended allottee's holding policy | The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral. |
| Basis for determining the amount to be paid | The issue price of the stock acquisition rights will be their accounting fair value as of the allotment date. The exercise price is ¥1 per share. The closing price, average share price, and discount or premium rate are Not disclosed. |
| Exercise price | ¥1 per share. No adjustment provisions. |
| Exercise period | Start Date 21 July 2026 / End date 20 July 2041 |
| Number of Stock Acquisition Rights | Total number issued: 599; number remaining unexercised: Not disclosed |
| Reason for acquisition without consideration | After the exercise period has expired or 5 years have elapsed from the date of retirement, A serious violation of laws, regulations or internal rules, If the holder is sentenced to imprisonment or a more severe penalty, If the holder assumes or agrees to assume a position as an officer or employee of a competing company without the Company's prior approval, If a successor to the rights dies, If the holder of the stock acquisition rights offers to waive all of them, If the Board of Directors resolves to acquire all or part of the stock acquisition rights |
| Categories and Number of Persons Covered | Category The Company's executive officers / Number of Employees 15 / Number of allocated shares 163,500 shares, Category Directors and others of the Company's group companies / Number of Employees 4 / Number of allocated shares 16,200 shares |
| Procedures under the Corporate Code of Conduct | Approved by the Compensation Committee and the Board of Directors on 28 May 2025. The specific issuance terms were determined by the Compensation Committee and the Board of Directors on 9 April 2026. |
Items this document does not state (14)
Total issue valueEstimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to enhance the motivation and morale of executive officers and others toward sustained improvement in performance and growth in corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.